Filana Therapeutics receives Nasdaq notice for sub-$1 minimum bid price noncompliance
FLNA•Nasdaq minimum bid-price notice
Nasdaq flagged Filana Therapeutics for noncompliance with the $1 minimum bid-price rule after 30 straight business days below $1.
Shares keep trading on the Nasdaq Capital Market under FLNA while the company gets 180 days, until March 16, 2027, to regain compliance.
Compliance requires a closing bid price of at least $1 for 10 consecutive business days during the cure period.
Failure to cure could trigger a delisting determination, with a possible appeal to a Nasdaq hearings panel.
